Combined TNF Inhibitor and Growth Factor Serum from Japan
Bulk mixed preparation of tumor necrosis factor (TNF) inhibitors like infliximab with growth factors (GF) for autoimmune disease modulation. HTS 3002.14.00 applies to such mixed immunological products (TNF, GF) obtained biotechnologically, excluding retail forms.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Include biotech origin certificates showing modification processes for TNF/GF regulation
• Avoid measured dose packaging; bulk drums qualify for 3002.14 over retail headings